Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: June 29, 2022

Details for Patent: 9,254,328

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,254,328 protect, and when does it expire?

Patent 9,254,328 protects TYGACIL and is included in one NDA.

This patent has thirty-one patent family members in twenty-five countries.

Summary for Patent: 9,254,328

Title:	Tigecycline compositions and methods of preparation
Abstract:	The present invention relates to novel tigecycline compositions with improved stability in both solid and solution states and processes for making these compositions. These compositions comprise tigecycline, a suitable carbohydrate, and an acid or buffer.
Inventor(s):	Fawzi; Mahdi B. (Morristown, NJ), Zhu; Tianmin (Monroe, NY), Shah; Syed M. (Delray Beach, FL)
Assignee:	Wyeth LLC (New York, NY)
Application Number:	14/604,924
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,254,328
Patent Claim Types: see list of patent claims	Composition; Formulation; Process;

Drugs Protected by US Patent 9,254,328

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pf Prism Cv	TYGACIL	tigecycline	POWDER;INTRAVENOUS	021821-001	Jun 15, 2005	AP	RX	Yes	Yes	See Plans and Pricing	See Plans and Pricing	Y				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,254,328

Subscribe to access the full database, or Try it Free
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	053827	See Plans and Pricing
Argentina	109500	See Plans and Pricing
Australia	2006223226	See Plans and Pricing
Brazil	PI0608464	See Plans and Pricing
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Dow

Merck

McKinsey

Moodys

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.